Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Multiple keratoacanthomas following the Moderna mRNA-1273 Covid-19 vaccination resolved with 5-FU treatment: Case Report
Fahad Ahmed;
Nashwah Memon;
Adel Haque
ABSTRACT
Cutaneous reactions have been commonly associated with the Moderna mRNA Covid-19 vaccine. Of the reported cutaneous side effects, there have not been any associations reported yet of keratoacanthoma after Covid-19 mRNA vaccination. We report a novel case of an 86 year old man who had an eruption of multiple keratoacanthomas 2 weeks after inoculation with the Moderna mRNA-1273 vaccine that resolved following treatment with intralesional 5-fluorouracil.
Citation
Please cite as:
Ahmed F, Memon N, Haque A
Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report